Literature DB >> 10602515

Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors.

M F DeCristofaro1, B L Betz, W Wang, B E Weissman.   

Abstract

The organization of genomic DNA into chromatin aids in the regulation of gene expression by limiting the access of transcriptional binding domains. The SWI/SNF family of chromatin-remodeling complexes, which are conserved from yeast to humans, open the chromatin to facilitate the transcriptional machinery to access their targets. The gene encoding the BAF47/hSNF5 subunit of the complex has been found mutated in both rhabdoid cell lines and in primary rhabdoid tumors. Since the pediatric tumors rhabdomyosarcoma (RMS) and Wilms' tumor (WT) share a similar genetic link with rhabdoid tumors, it was hypothesized that they may also show alterations of the BAF47 gene. Using primary tumors, the BAF47 protein was detected in all WT but less than 75% of the RMS tested. In cell lines, the BAF47 protein was missing in all rhabdoid cell lines and one RMS cell line. Analysis of sample DNA displayed either a mutation or deletion of the BAF47 gene in all samples negative for the protein. Several other subunits of the human SWI/SNF complex, including BRG1 which is the subunit directly interacting with the Rb tumor suppressor gene, were detected in all tumor samples. Alteration of BAF47 may be a genetic marker associated with the poor prognosis seen in all rhabdoid tumors but only some RMS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602515     DOI: 10.1038/sj.onc.1203168

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

Review 1.  Chapter 5. Nuclear actin-related proteins in epigenetic control.

Authors:  Richard B Meagher; Muthugapatti K Kandasamy; Elizabeth C McKinney; Eileen Roy
Journal:  Int Rev Cell Mol Biol       Date:  2009       Impact factor: 6.813

Review 2.  Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer.

Authors:  Bernard Weissman; Karen E Knudsen
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

3.  Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.

Authors:  Roger E McLendon; Adesina Adekunle; Veena Rajaram; Mehmet Koçak; Susan M Blaney
Journal:  Arch Pathol Lab Med       Date:  2011-08       Impact factor: 5.534

4.  Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice.

Authors:  C J Guidi; A T Sands; B P Zambrowicz; T K Turner; D A Demers; W Webster; T W Smith; A N Imbalzano; S N Jones
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  BRG-1 is required for RB-mediated cell cycle arrest.

Authors:  M W Strobeck; K E Knudsen; A F Fribourg; M F DeCristofaro; B E Weissman; A N Imbalzano; E S Knudsen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

6.  Transcription activator interactions with multiple SWI/SNF subunits.

Authors:  Kristen E Neely; Ahmed H Hassan; Christine E Brown; LeAnn Howe; Jerry L Workman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

7.  BRG1 controls the activity of the retinoblastoma protein via regulation of p21CIP1/WAF1/SDI.

Authors:  Hyeog Kang; Kairong Cui; Keji Zhao
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

8.  A comparative genomic approach for identifying synthetic lethal interactions in human cancer.

Authors:  Raamesh Deshpande; Michael K Asiedu; Mitchell Klebig; Shari Sutor; Elena Kuzmin; Justin Nelson; Jeff Piotrowski; Seung Ho Shin; Minoru Yoshida; Michael Costanzo; Charles Boone; Dennis A Wigle; Chad L Myers
Journal:  Cancer Res       Date:  2013-08-26       Impact factor: 12.701

9.  SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.

Authors:  Darmood Wei; Dennis Goldfarb; Shujie Song; Courtney Cannon; Feng Yan; Donastas Sakellariou-Thompson; Michael Emanuele; Michael B Major; Bernard E Weissman; Yasumichi Kuwahara
Journal:  Mol Cancer Res       Date:  2014-07-09       Impact factor: 5.852

Review 10.  Epigenomic regulation of oncogenesis by chromatin remodeling.

Authors:  R Kumar; D-Q Li; S Müller; S Knapp
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.